JORDAN ROBERTS: Open Payments
NPI 1588043871 · HOLLADAY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,607 in 73 payments from 25 companies in 2025. Trend: 2023 $3,507 · 2024 $1,550 · 2025 $1,607
Food & beverage: $1,607
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 5 | $207 |
| ABBVIE INC. | 8 | $186 |
| Janssen Pharmaceuticals, Inc | 3 | $152 |
| UCB, Inc. | 7 | $149 |
| ViiV Healthcare Company | 7 | $147 |
| AstraZeneca Pharmaceuticals LP | 5 | $97 |
| GlaxoSmithKline, LLC. | 6 | $95 |
| Amgen Inc. | 5 | $89 |
| Lilly USA, LLC | 4 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $70 |
Products named: SPRAVATO, Bimzelx, APRETUDE, Yeztugo, SHINGRIX, EVENITY, RINVOQ, VRAYLAR.
Industry payments across UT — which companies pay providers there.
